YD Bio Ltd
Research YD Bio Ltd (YDES) on Bullrun: market cap USD 476.69M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerYDES
- ExchangeNASDAQ
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 476.69M
- Financial periodQ2 2026
Valuation Snapshot
latest market cap is USD 476.69M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 596.82K | -USD 8.31M | -USD 8.04M | 28.1% | -0.12 | USD 6.01M | USD 6.76K | -USD 2.86M |
| FY2024 | USD 510.36K | -USD 1.41M | -USD 4.75M | 30.4% | -0.02 | USD 3.13M | USD 22.56K | USD 6.59M |
| FY2023 | USD 350.13K | USD 13.56K | -USD 55.95K | 43.8% | 0 | USD 87.10K | USD 47.58K | USD 22.99K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 476.69M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 859.66M | n/a | n/a | n/a |
About YD Bio Ltd
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye fatigue;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is YD Bio Ltd's market cap?
YD Bio Ltd's market capitalization is USD 476.69M.
What does YD Bio Ltd do?
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan.